(SDZNY - SANDOZ GROUP AG)

company profile

Sandoz Group AG develops, manufactures, and markets generic and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, supportive care, rare diseases, diabetes, immunology, endocrinology, neurology, osteoporosis, nephrology, hematology, and ophthalmology. It also provides a portfolio of active pharmaceutical ingredients and finished dosage forms. The company has a strategic collaboration with Shanghai Henlius Biotech, Inc. to broaden patient access to biosimilar medicines. Sandoz Group AG was founded in 1886 and is headquartered in Basel, Switzerland.

Sandoz Group ADR (SDZNY) is trading at 96.615

Open Price
97.94
Previous close
96.615
Previous close
96.615
P/E Ratio
0
Sector
Health Care
Shares outstanding
432692617
Primary exchange
OTC Markets
ISIN
US7999261008